Recombinant Absidia glauca ACT1 Protein ，His & Myc

ACT1 is a crucial protein involved in various cellular processes, primarily known for its role in signaling pathways that regulate immune responses and inflammation. Predominantly identified in yeast and higher eukaryotic organisms, ACT1 functions as an actin-binding protein, significantly influencing cytoskeletal dynamics and cellular motility. Research has increasingly focused on the recombinant expression of ACT1 to understand its structure-function relationships and to explore its potential applications in biotechnology and medicine. The ability to produce ACT1 recombinantly allows scientists to manipulate and study its interactions with other proteins and cellular components in vitro, providing insights into its mechanisms and effects in vivo. Furthermore, ACT1 has been implicated in various diseases, including cancer and autoimmune disorders, which makes its study particularly relevant for developing therapeutic strategies. The enhancement of recombinant protein technologies has paved the way for more comprehensive studies of ACT1, offering opportunities for drug discovery and the development of novel therapeutics targeting ACT1-related pathways. As such, the ongoing research into ACT1 recombinant proteins holds promise for significant advancements in both fundamental biology and clinical applications.